A pioneering clinical trial is exploring whether lab-engineered stem cells can restore dopamine production in people with Parkinson’s disease. In Parkinson’s disease, the problem starts deep in the brain, where a small group of cells gradually fails. The condition is…
Continue reading with a subscription
This article is available to subscribers. Subscribe to read it in full, or sign in if you already have an account.